We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock

Delisted

INBX was delisted on the 29th of May, 2024.

51 hedge funds and large institutions have $513M invested in Inhibrx, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

107% more capital invested

Capital invested by funds: $248M → $513M (+$266M)

59% more funds holding

Funds holding: 3251 (+19)

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
51
Holders Change
+19
Holders Change %
+59.38%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
10
Reduced
7
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AIG
51
American International Group
New York
$156 +$126K +4,725 New
LGM
52
Logos Global Management
California
-$5.61M -311,578 Closed
Franklin Resources
53
Franklin Resources
California
-$3.6M -200,000 Closed
ECM
54
Endurant Capital Management
California
-$647K -35,935 Closed
MIM
55
Monashee Investment Management
Massachusetts
-$479K -26,623 Closed
Wellington Management Group
56
Wellington Management Group
Massachusetts
-$364K -20,202 Closed
MFS
57
Mirabella Financial Services
United Kingdom
-$331K -18,365 Closed
MWNA
58
Marshall Wace North America
New York
-$324K -17,992 Closed
ECM
59
ExodusPoint Capital Management
New York
-$254K -14,115 Closed
MS
60
Maven Securities
Jersey
-$185K -10,421 Closed
Norges Bank
61
Norges Bank
Norway
-$180K -10,000 Closed

INBX Hedge Fund Activity: Q4 2020 in Review

51 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q4 2020, worth a combined $513M — up 107% from $248M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new INBX positions and 10 closed out — a net gain of 19 holders — while 10 added to existing stakes and 7 trimmed.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $28.1M. The largest seller was Logos Global Management, exiting entirely with an estimated $5.61M sold.

  • 51 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q4 2020, up from 32 in Q3 2020.
  • Funds reported $513M of Inhibrx, Inc. Common Stock stock for Q4 2020, up 107% quarter-over-quarter.
  • 29 funds opened new Inhibrx, Inc. Common Stock positions in Q4 2020 and 10 closed out, a net change of +19 holders.
  • The largest Inhibrx, Inc. Common Stock buyer in Q4 2020 was ArrowMark Colorado Holdings, an estimated $28.1M added.
  • The largest Inhibrx, Inc. Common Stock seller in Q4 2020 was Logos Global Management, an estimated $5.61M sold.

Based on aggregated 13F filings for Q4 2020.